Literature DB >> 25231307

The conserved disulfide bond within domain II of Epstein-Barr virus gH has divergent roles in membrane fusion with epithelial cells and B cells.

Britta S Möhl1, Karthik Sathiyamoorthy2, Theodore S Jardetzky2, Richard Longnecker3.   

Abstract

UNLABELLED: Epstein-Barr virus (EBV) infects target cells via fusion with cellular membranes. For entry into epithelial cells, EBV requires the herpesvirus conserved core fusion machinery, composed of glycoprotein B (gB) and gH/gL. In contrast, for B cell fusion it requires gB and gH/gL with gp42 serving as a cell tropism switch. The available crystal structures for gH/gL allow the targeted analysis of structural determinants of gH to identify functional regions critical for membrane fusion. Domain II of EBV gH contains two disulfide bonds (DBs). The first is unique for EBV and closely related gammaherpesviruses. The second is conserved across the beta- and gammaherpesviruses and is positioned to stabilize a putative syntaxin-like bundle motif. To analyze the role of these DBs in membrane fusion, gH was mutated by amino acid substitution of the DB cysteines. Mutation of the EBV-specific DB resulted in diminished gH/gL cell surface expression that correlated with diminished B cell and epithelial cell fusion. In contrast, mutation of the conserved DB resulted in wild-type-like B cell fusion, whereas epithelial cell fusion was greatly reduced. The gH mutants bound well to gp42 but had diminished binding to epithelial cells. Tyrosine 336, located adjacent to cysteine 335 of the conserved DB, also was found to be important for DB stabilization and gH/gL function. We conclude that the conserved DB has a cell type-specific function, since it is important for the binding of gH to epithelial cells initiating epithelial cell fusion but not for fusion with B cells and gp42 binding. IMPORTANCE: EBV predominantly infects epithelial and B cells in humans, which can result in EBV-associated cancers, such as Burkitt and Hodgkin lymphoma, as well as nasopharyngeal carcinoma. EBV is also associated with a variety of lymphoproliferative disorders, typically of B cell origin, observed in immunosuppressed individuals, such as posttransplant or HIV/AIDS patients. The gH/gL complex plays an essential but still poorly characterized role as an important determinant for EBV cell tropism. In the current studies, we found that mutants in the DB C278/C335 and the neighboring tyrosine 336 have cell type-specific functional deficits with selective decreases in epithelial cell, but not B cell, binding and fusion. The present study brings new insights into the gH function as a determinant for epithelial cell tropism during herpesvirus-induced membrane fusion and highlights a specific gH motif required for epithelial cell fusion.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25231307      PMCID: PMC4248955          DOI: 10.1128/JVI.02272-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Structure of the Epstein-Barr virus gp42 protein bound to the MHC class II receptor HLA-DR1.

Authors:  Maureen M Mullen; Keith M Haan; Richard Longnecker; Theodore S Jardetzky
Journal:  Mol Cell       Date:  2002-02       Impact factor: 17.970

2.  Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus.

Authors:  Corina M Borza; Lindsey M Hutt-Fletcher
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

3.  Epstein-Barr virus enters B cells and epithelial cells by different routes.

Authors:  N Miller; L M Hutt-Fletcher
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

4.  Analysis of fusion using a virus-free cell fusion assay.

Authors:  Marisa P McShane; Richard Longnecker
Journal:  Methods Mol Biol       Date:  2005

5.  The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells.

Authors:  Q Li; S M Turk; L M Hutt-Fletcher
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

6.  Induction of antibodies to the Epstein-Barr virus glycoprotein gp85 with a synthetic peptide corresponding to a sequence in the BXLF2 open reading frame.

Authors:  D E Oba; L M Hutt-Fletcher
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

7.  The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation.

Authors:  M K Spriggs; R J Armitage; M R Comeau; L Strockbine; T Farrah; B Macduff; D Ulrich; M R Alderson; J Müllberg; J I Cohen
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

8.  Chaperone functions common to nonhomologous Epstein-Barr virus gL and Varicella-Zoster virus gL proteins.

Authors:  Q Li; C Buranathai; C Grose; L M Hutt-Fletcher
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

9.  Use of gHgL for attachment of Epstein-Barr virus to epithelial cells compromises infection.

Authors:  Corina M Borza; Andrew J Morgan; Susan M Turk; Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Mutational analyses of Epstein-Barr virus glycoprotein 42 reveal functional domains not involved in receptor binding but required for membrane fusion.

Authors:  Amanda L Silva; Jasmina Omerovic; Theodore S Jardetzky; Richard Longnecker
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more
  11 in total

1.  Mutations in Pseudorabies Virus Glycoproteins gB, gD, and gH Functionally Compensate for the Absence of gL.

Authors:  Christina Schröter; Melina Vallbracht; Jan Altenschmidt; Sabrina Kargoll; Walter Fuchs; Barbara G Klupp; Thomas C Mettenleiter
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

2.  Epstein-Barr Virus Fusion with Epithelial Cells Triggered by gB Is Restricted by a gL Glycosylation Site.

Authors:  Britta S Möhl; Jia Chen; Seo Jin Park; Theodore S Jardetzky; Richard Longnecker
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

3.  An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus.

Authors:  Joost Snijder; Michael S Ortego; Connor Weidle; Andrew B Stuart; Matthew D Gray; M Juliana McElrath; Marie Pancera; David Veesler; Andrew T McGuire
Journal:  Immunity       Date:  2018-04-17       Impact factor: 31.745

4.  Inhibition of EBV-mediated membrane fusion by anti-gHgL antibodies.

Authors:  Karthik Sathiyamoorthy; Jiansen Jiang; Britta S Möhl; Jia Chen; Z Hong Zhou; Richard Longnecker; Theodore S Jardetzky
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-22       Impact factor: 11.205

5.  A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge In Vivo.

Authors:  Junping Hong; Ling Zhong; Qingbing Zheng; Qian Wu; Zhenghui Zha; Dongmei Wei; Haiwen Chen; Wanlin Zhang; Shanshan Zhang; Yang Huang; Kaiyun Chen; Junyu Chen; Shaowei Li; Mu-Sheng Zeng; Yi-Xin Zeng; Ningshao Xia; Xiao Zhang; Miao Xu; Yixin Chen
Journal:  J Virol       Date:  2022-03-29       Impact factor: 6.549

6.  Comparative Mutagenesis of Pseudorabies Virus and Epstein-Barr Virus gH Identifies a Structural Determinant within Domain III of gH Required for Surface Expression and Entry Function.

Authors:  Britta S Möhl; Christina Schröter; Barbara G Klupp; Walter Fuchs; Thomas C Mettenleiter; Theodore S Jardetzky; Richard Longnecker
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

7.  Epithelial cell infection by Epstein-Barr virus.

Authors:  Jia Chen; Richard Longnecker
Journal:  FEMS Microbiol Rev       Date:  2019-11-01       Impact factor: 16.408

8.  Ephrin Receptor A4 is a New Kaposi's Sarcoma-Associated Herpesvirus Virus Entry Receptor.

Authors:  Jia Chen; Xianming Zhang; Samantha Schaller; Theodore S Jardetzky; Richard Longnecker
Journal:  mBio       Date:  2019-02-19       Impact factor: 7.867

9.  A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus.

Authors:  Qian-Ying Zhu; Sisi Shan; Jinfang Yu; Si-Ying Peng; Cong Sun; Yanan Zuo; Lan-Yi Zhong; Shu-Mei Yan; Xiao Zhang; Ziqing Yang; Yong-Jian Peng; Xuanling Shi; Su-Mei Cao; Xinquan Wang; Mu-Sheng Zeng; Linqi Zhang
Journal:  Nat Commun       Date:  2021-11-16       Impact factor: 14.919

Review 10.  Structural and Mechanistic Insights into the Tropism of Epstein-Barr Virus.

Authors:  Britta S Möhl; Jia Chen; Karthik Sathiyamoorthy; Theodore S Jardetzky; Richard Longnecker
Journal:  Mol Cells       Date:  2016-04-06       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.